OTC Healthcare in the Czech Republic
Euromonitor International's OTC Healthcare in the Czech Republic market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 89 | Publication date: Nov 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Continued Good Growth Due to Rising Economic Growth and Awareness
OTC healthcare saw good growth in 2006 over the previous year, as rising income levels encouraged consumers to trade up. In addition, many product areas benefited from advertising towards the end of the review period, with this notably boosting acetaminophen, antacids and haemorrhoid treatments. The health and wellness trend also spurred growth, with a strong growth for herbal/traditional products and for vitamins and dietary supplements.
Eye Care Boosted by Longer Work Hours and Allergies
Eye care saw the most dynamic current value growth in 2006 over the previous year. This was supported by advertising for standard eye care that linked lengthy computer usage with eye strain. With Czechs working increasingly long hours, this boosted interest in these products. In addition, a rising incidence in allergies also expanded the consumer base.
Zentiva Expands Lead With Wide Range and Reasonable Prices
Zentiva continued to be the leading player in OTC healthcare in 2006 and expanded its share further. The company offers a wide range of generic products, which are popular with consumers due to their low prices and high quality. In addition, the company used advertising to boost sales in the latter part of the review period, with this notably boosting its performance in analgesics.
Chemists/Pharmacies Continues to Dominate
There was some liberalisation for OTC healthcare distribution during the review period, with a wider range of products permitted for sale beyond the pharmacy network. However, chemists/pharmacies and drugstores/parapharmacies continue to be the most significant channels, with most consumers preferring to seek guidance from a pharmacist before making their selection.
Continuation of Growth Due to Rise in Self-medication
The Czech government is keen to encourage a higher degree of self-medication during the forecast period, with this expected to result in continuing good growth. It is likely that a wider range of products will be made available beyond the pharmacy network. In addition, consumers will generally become more confident in seeking advice from a pharmacist, rather than going to the trouble of visiting a doctor, particularly for less serious aches and pains.
Table of contents
OTC HEALTHCARE IN THE CZECH REPUBLIC : MARKET INSIGHT
EXECUTIVE SUMMARY
Continued Good Growth Due to Rising Economic Growth and Awareness
Eye Care Boosted by Longer Work Hours and Allergies
Zentiva Expands Lead With Wide Range and Reasonable Prices
Chemists/Pharmacies Continues to Dominate
Continuation of Growth Due to Rise in Self-medication
KEY TRENDS AND DEVELOPMENTS
Good Economic Performance Boosts Sales
Urbanisation Shapes Growth
Limited Distribution Reduces Consumer Access
Growing Interest in Health and Wellness
Child-specific OTC Healthcare Hindered by High Prices and Low Awareness
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
Table 2 Consumer Expenditure on Health Goods and Medical Services 2001-2006
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 5 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 6 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 7 Penetration of Private Label by Sector 2002-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Vitamins & Dietary Supplements Registration and Classification
Generics
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - CZECH REPUBLIC
HERBACOS BOFARMA SRO - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Herbacos Bofarma sro: Key Facts
Summary 3 Herbacos Bofarma sro: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Herbacos Bofarma sro: Competitive Position 2006
MEDICAMENTA VYSOKE MYTO AS - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Medicamenta Vysoke Myto as: Key Facts
Summary 6 Medicamenta Vysoke Myto as: Operational Indicators 2004/2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Medicamenta Vysoke Myto as: Competitive Position 2006
WALMARK AS - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Walmark as: Key Facts
Summary 9 Walmark as: Operational Indicators 2004-2005
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Walmark as: Competitive Position 2006
ZENTIVA AS - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Zentiva as: Key Facts
Summary 12 Zentiva as: Operational Indicators 2005-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Zentiva as: Competitive Position 2006
ANALGESICS IN THE CZECH REPUBLIC
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2001-2006
Table 13 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Topical Analgesics 2001/2006
Table 15 Analgesics Company Shares by Retail Value 2002-2006
Table 16 Analgesics Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE CZECH REPUBLIC
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 21 Sales of Decongestants by Type: Value 2001-2006
Table 22 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN THE CZECH REPUBLIC
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 32 Herbal vs Standard Digestive Remedies 2001/2006
Table 33 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 34 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN THE CZECH REPUBLIC
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 39 Herbal vs Standard Medicated Skin Care 2001/2006
Table 40 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 41 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 42 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 43 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 44 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 45 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN THE CZECH REPUBLIC
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 48 Sales of Vitamins by Type: Value 2001-2006
Table 49 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 50 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 51 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 52 Vitamins Brand Shares by Retail Value 2003-2006
Table 53 Sales of Dietary Supplements by Type: Value 2001-2006
Table 54 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 55 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN THE CZECH REPUBLIC
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 58 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 61 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 62 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
EYE CARE IN THE CZECH REPUBLIC
OVERVIEW
SECTOR DATA
Table 65 Sales of Eye Care by Subsector: Value 2001-2006
Table 66 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 67 Eye Care Company Shares by Retail Value 2002-2006
Table 68 Eye Care Brand Shares by Retail Value 2003-2006
Table 69 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 70 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN THE CZECH REPUBLIC
OVERVIEW
ADULT MOUTHCARE IN THE CZECH REPUBLIC
OVERVIEW
CALMING AND SLEEPING PRODUCTS IN THE CZECH REPUBLIC
OVERVIEW
WOUND TREATMENTS IN THE CZECH REPUBLIC
OVERVIEW
SECTOR DATA
Table 71 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 72 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 73 Wound Treatments Company Shares by Retail Value 2002-2006
Table 74 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 75 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 76 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
EMERGENCY CONTRACEPTION IN THE CZECH REPUBLIC
OVERVIEW